DE69711868D1 - Adenosin-derivate - Google Patents

Adenosin-derivate

Info

Publication number
DE69711868D1
DE69711868D1 DE69711868T DE69711868T DE69711868D1 DE 69711868 D1 DE69711868 D1 DE 69711868D1 DE 69711868 T DE69711868 T DE 69711868T DE 69711868 T DE69711868 T DE 69711868T DE 69711868 D1 DE69711868 D1 DE 69711868D1
Authority
DE
Germany
Prior art keywords
3alkyl
pct
date nov
nitrogen
nrarb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69711868T
Other languages
English (en)
Other versions
DE69711868T2 (de
Inventor
Frank Ellis
Stephen Swanson
Peter Cousins
Brian Cox
Michael Pennell
David Eldred
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE69711868D1 publication Critical patent/DE69711868D1/de
Application granted granted Critical
Publication of DE69711868T2 publication Critical patent/DE69711868T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69711868T 1996-05-14 1997-05-13 Adenosin-derivate Expired - Lifetime DE69711868T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9610031.8A GB9610031D0 (en) 1996-05-14 1996-05-14 Chemical compounds
PCT/EP1997/002403 WO1997043300A1 (en) 1996-05-14 1997-05-13 Adenosine derivatives

Publications (2)

Publication Number Publication Date
DE69711868D1 true DE69711868D1 (de) 2002-05-16
DE69711868T2 DE69711868T2 (de) 2002-10-10

Family

ID=10793664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711868T Expired - Lifetime DE69711868T2 (de) 1996-05-14 1997-05-13 Adenosin-derivate

Country Status (9)

Country Link
US (1) US5998388A (de)
EP (1) EP0901499B1 (de)
JP (1) JP2001503382A (de)
AT (1) ATE215958T1 (de)
AU (1) AU2896197A (de)
DE (1) DE69711868T2 (de)
ES (1) ES2175405T3 (de)
GB (1) GB9610031D0 (de)
WO (1) WO1997043300A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723589D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723590D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
EP1303528A1 (de) * 2000-07-12 2003-04-23 Nikken Chemicals Company, Limited Adenosin-verbindung und diese enthaltende pharmazeutische zusammenstellung
GB2372742A (en) * 2001-03-03 2002-09-04 Univ Leiden C2,5'-Disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and their different uses
GB0105469D0 (en) * 2001-03-06 2001-04-25 Glaxo Group Ltd Medicaments
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
US6995148B2 (en) * 2001-04-05 2006-02-07 University Of Pittsburgh Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160797A (en) * 1979-05-31 1980-12-13 Ajinomoto Co Inc Purine nucleoside derivative
US5219840A (en) * 1987-04-06 1993-06-15 Sandoz Ltd. Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
DK62592D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine
DK155292D0 (da) * 1992-12-23 1992-12-23 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
US5688774A (en) * 1993-07-13 1997-11-18 The United States Of America As Represented By The Department Of Health And Human Services A3 adenosine receptor agonists
DE69428536T2 (de) * 1993-07-13 2002-06-06 Nasa A3 -adenosin -rezeptor agonisten
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
WO1997033591A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals

Also Published As

Publication number Publication date
GB9610031D0 (en) 1996-07-17
JP2001503382A (ja) 2001-03-13
ATE215958T1 (de) 2002-04-15
ES2175405T3 (es) 2002-11-16
EP0901499A1 (de) 1999-03-17
AU2896197A (en) 1997-12-05
DE69711868T2 (de) 2002-10-10
WO1997043300A1 (en) 1997-11-20
US5998388A (en) 1999-12-07
EP0901499B1 (de) 2002-04-10

Similar Documents

Publication Publication Date Title
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
NO982330L (no) Pyrazolderivater, fremgangsmÕte for fremstilling derav og farmas°ytiske preparater inneholdende nevnte derivater
HUP0001446A2 (hu) HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
HUP0203438A2 (hu) Foszfodiészteráz gátló hatású 5-(2-helyettesített-5-heterociklilszulfonilpirid-3-il)-dihidropirazolo[4,3-d]-pirimidin-7-on-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69310367D1 (de) Anilide-derivate
HUP0104204A2 (hu) COX-2 inhibítor hatású pirazolo-piridin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69932173D1 (de) Adenine-derivate
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
NO983707D0 (no) Kinazolin-derivater som antitumor-midler
HUP0204143A2 (en) Tricyclic 1-benzylpyrazoles-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them
ITRM20010356A1 (it) "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
ATE215958T1 (de) Adenosin-derivate
AR009938A1 (es) Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos
PT902684E (pt) Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos
HUP0101469A2 (hu) 5-[(2-Imidazolidinilidén)-amino]-benzimidazol-származékok, előállításuk és alkalmazásuk javított metabolikus stabilitású alfa-adrenoceptor agonistákként
ES2091126T3 (es) Nuevos compuestos biciclicos de pirimidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE337827T1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
AR017146A1 (es) Compuestos de 1-(fenil-sustituido)-5-(4-metilsulfonilfenil)pirazol; procedimiento para prepararlos, las composiciones farmaceuticas que los contienen,los agentes inhibidores de la cox-ii que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos.
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
DK0765322T3 (da) Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister
IT1286141B1 (it) Derivati diammidici dell'acido antranilico ad attivita' antigastrinica procedimento per la loro preparazione e loro uso farmaceutico.
HUP0003555A2 (hu) Gombaellenes hatású triazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjük
EE9900238A (et) Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
NO954316D0 (no) Benzo(f)kinoksalidinonderivater, deres fremstilling og anvendelse i legemidler